Medibank share price lifts despite shareholder class action

The health insurer has been hit with another class action relating to its 2022 cyber-attack.

| More on:
a woman in a business suit stands with her arms folded in the background of a statue of lady justice wearing robes, carrying a sword and holding the scales of justice.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • The Medibank share price is gaining 0.76% to trade at $3.295 right now
  • That's despite news the company is facing a shareholder class action
  • The action alleges Medibank breached continuous disclosure obligations and ASX listing rules 

The Medibank Private Ltd (ASX: MPL) share price is in the green on Thursday despite the company facing a shareholder class action.

It comes on the back of a massive cyber-attack that saw the data of 9.7 million Australians in the hands of hackers late last year.

Right now, the Medicare share price is $3.295, 0.76% higher than its previous close.

Created with Highcharts 11.4.3Medibank Private Ltd PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

For comparison, the S&P/ASX 200 Index (ASX: XJO) has gained 0.97% at the time of writing.

Let's take a closer look at the latest news from the ASX 200 health insurance giant.

Medibank faces shareholder class action

The Medibank share price appears not to have been impacted by news a shareholder class action against the company has been filed in the Supreme Court of Victoria.

The action alleges the company breached continuous disclosure obligations and ASX listing rules by not disclosing information related to alleged deficiencies in its cyber security systems.

Medibank intends to defend the action, understood to have been brought on behalf of investors who bought shares in Medibank between July 2019 and October 2022.

The law firm behind the legal action is United States-based Quinn Emanuel.

Medibank revealed it had been served with the action after the market closed on Wednesday.

The ASX 200 company bore $26.2 million of costs related to the cyber-attack last half.

It expects to fork out another $13.8 million to $18.8 million this half. That's before any potential remediation, regulatory, or litigation costs.

The shareholder class action is the second suit faced by the company as a result of the breach.

Medicare vowed to defend itself against a class action brought on behalf of current and former customers last month. It included allegations of breach of contract, contraventions of Australian consumer law, and breach of equitable obligations of confidence.

It was filed in the Federal Court of Australia and brought by law firm Baker McKenzie, funded by Omni Bridgeway.

Medibank share price snapshot

The Medibank share price tumbled 18% when the company revealed the cyber-attack in October, and it hasn't quite recovered yet. It remains 6% lower than it was prior to its ill-fated announcement.

Though, it has gained 6% over the last 12 months and 13% so far this year.

Comparatively, the ASX 200 has gained 3% year to date and has fallen 5% since this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Which small cap ASX share is jumping 10% on strong results

Investors have been bidding this stock higher today. But why?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why Macquarie forecasts 30-50% upside for these ASX All Ords healthcare stocks

Macquarie updated its target price on these three ASX All Ords healthcare stocks.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX 200 stock is jumping 10% on big news

This stock is catching the eye with a strong gain on Thursday. But why?

Read more »

a young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Healthcare Shares

Down 15% since January, are Cochlear shares now a buy?

Let's see what analysts are saying about this blue chip.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Healthcare Shares

Guess which popular ASX 200 stock is up nearly 60% in less than 2 months?

Investors who bought this ASX 200 stock in the recent dip have been strongly rewarded.

Read more »

A senior pharmacist talks to a customer at the counter in a shop.
Healthcare Shares

Are Sigma Healthcare shares a good buy now after the merger with Chemist Warehouse?

Sigma Healthcare shares have soared 154% in 12 months. Can this stellar run continue?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

Up 34% since April, ASX 300 healthcare stock lifts off again today on new milestone

The ASX 300 healthcare stock has been on a tear since hitting one-year lows in April.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Should I buy the dip on CSL shares?

A leading fund manager gives his verdict on the growth prospects for CSL shares.

Read more »